Skip to main content

Free Content Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

We report a retrospective and descriptive study of four immunocompromised patients (three with HIV‐1 and one with idiopathic CD4+‐lymphopenia) with relapsing visceral leishmaniasis seen at the Hospital for Tropical Diseases, London, in whom pentamidine was used as secondary prophylaxis to prevent relapse. Patients experienced between one and four relapses before commencing prophylaxis with subsequent relapse‐free periods ranging from 5 to 98 months. Based on these observational data, we recommend large trials to investigate the efficacy of pentamidine over other agents in preventing relapse of VL in the immunocompromised patient.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: HIV; Leishmaniasis; VIH; VIH+; hospedero inmunocomprometido; hôte immunodéprimé; immunocompromised host; leishmaniasis; leishmaniose; pentamidina; pentamidine; profilaxis; prophylaxie; prophylaxis

Language: English

Document Type: Research Article

Affiliations:  Hospital for Tropical Diseases, London, UK

Publication date: 2009-09-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more